Video

Ilana Cass on Potential Consequences of Preventive Surgery

Author(s):

Ilana Cass, M.D.
Conference|FORCE Conference

Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.

Ilana Cass, M.D. of Cedars-Sinai Medical Center, discusses the potential side effects that may occur after a preventive surgery for ovarian cancer. Some of the effects are yet unknown and standards for screening need to be developed.

Related Videos
Image of woman with blonde hair.
Image of a man in a suit.
Image of woman with brown hair.
Image of a man with short black hair.
Image of a woman with wavy blonde hair wearing glasses.
Image of man with black hair.
Image of a woman with layered hair, wearing a bright blue cardigan.
Image of a man with short black hair.
Image of man with gray hair.
Related Content
Illustration of a person holding a magnifying glass next to paperwork and pills.
December 3rd 2024

Nemvaleukin Shows Manageable Safety Profile in Advanced Solid Tumors

Ashley Chan
In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity and tolerability.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of a woman with short gray hair, wearing rectangular-framed glasses.
November 19th 2024

My Top 10 List for Living With Cancer

Kelly Irvin
Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of radiation targeting cancer cells.
November 5th 2024

Common Prostate Cancer Radiation Questions Answered

Alex Biese
Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.
"FDA" text.
November 1st 2024

Application Submitted to FDA for Avutometinib Plus Defactinib in Rare Ovarian Cancer

Darlene Dobkowski, MA
The FDA received the New Drug Application for avutometinib plus defactinib as a potential treatment option for previously treated low-grade serous ovarian cancer.